Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 2/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.46 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.46 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.44 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 5/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15345291 | 0.85 | LMNA (0.44) | CHRNB2CHRNA4CHRNB4CHRNA3LMNA | |
| SCHEMBL28994502 | 0.82 | CHRNB2 (0.50) | CHRNB2CHRNA4CHRNB4CHRNA3LMNA | |
| SCHEMBL28945786 | 0.82 | CHRNB2 (0.50) | CHRNB2CHRNA4CHRNB4CHRNA3LMNA | |
| SCHEMBL28945769 | 0.82 | CHRNB2 (0.50) | CHRNB2CHRNA4CHRNB4CHRNA3LMNA | |
| SCHEMBL28945804 | 0.82 | CHRNB2 (0.50) | CHRNB2CHRNA4CHRNB4CHRNA3LMNA | |
| SCHEMBL24632190 | 0.82 | CHRNB2 (0.50) | CHRNB2CHRNA4CHRNB4CHRNA3LMNA | |
| SCHEMBL28401987 | 0.82 | CHRNB2 (0.50) | CHRNB2CHRNA4CHRNB4CHRNA3LMNA | |
| SCHEMBL11248277 | 0.82 | CHRNB2 (0.50) | CHRNB2CHRNA4CHRNB4CHRNA3LMNA | |
| SCHEMBL28945776 | 0.82 | CHRNB2 (0.50) | CHRNB2CHRNA4CHRNB4CHRNA3LMNA | |
| SCHEMBL28487080 | 0.82 | CHRNB2 (0.50) | CHRNB2CHRNA4CHRNB4CHRNA3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119140149-A | Catalyst for preparing diisocyanate from carbamate and diisocyanate preparation method | 山东华鲁恒升化工股份有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-118085276-A | High-crosslinking high-performance non-isocyanate polyurethane and preparation method and application thereof | 南京工业大学 | 2024-05-28 | — | — | CN | disclosed |
| CN-113024417-B | Method and device for strengthening separation in isocyanate preparation | 中国科学院过程工程研究所 | 2021-08-31 | — | — | CN | disclosed |
| CN-113024417-A | Method and device for strengthening separation in isocyanate preparation | 中国科学院过程工程研究所 | 2021-06-25 | — | — | CN | disclosed |
| CN-1796439-A | Environment friendly method for synthesizing polyurethane | UNIV HUADONG TECHNOLOGY (CN) | 2006-07-05 | — | — | CN | disclosed |
| US-6998364-B2 | Process for the formation of urethane via transcarbamation | RHODIA CHIMIE (FR) | 2006-02-14 | — | — | US | disclosed |
| US-20040044242-A1 | Use as catalyst for forming urethanes,of fluorinated and of trivalent metal acid salts, composition containing same and methods using same | VENCOREX FRANCE (FR) | 2004-03-04 | — | — | US | disclosed |
| CN-1469888-A | Use as catalyst for forming urethanes, of fluorinated and trivalent metal acid salts, composition containing same and methods using same | ���ǻ�ѧ��˾ | 2004-01-21 | — | — | CN | disclosed |
| US-5235062-A | Transesterification of N-hydroxyethyloxazolidine with dicarbamate of diamine in presence of alkali metal alcoholate catalyst | ENICHEM SYNTHESIS S.P.A. (IT) | 1993-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040044242-A1 | Use as catalyst for forming urethanes,of fluorinated and of trivalent metal acid salts, composition containing same and methods using same | PHF2, UBE2T, UHRF1 | CHRNB2 1831/4885CHRNA4 2192/4885CHRNB4 2010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.